In summary, our findings highlight for the first time nuclear YY1 expression as a promising independent prognostic biomarker in BC, particularly in underrepresented populations, such as Latin American patients, when quantified using DP and a tumor-focused TMA analysis. Here, YY1 is linked to neoplasm.